Subgroups included age, baseline ECOG status, gender, smoking status, baseline brain metastasis, PD-L1 TPS (≥ 50% or < 50%), investigator choice of chemotherapy, predominant tumor histology, race (white vs. non-white), metastatic stage and non-East Asian geographic region. This evidence concerns the gene CD274 and neoplasm.